FUTURE PERFECT
Making health and care
maximally intelligent
Welcome to Future Perfect (Healthcare).
We make healthcare maximally intelligent by offering expert information for patients’ professional care and self-care, based on their diseases, genotypes, medicines and lifestyles.
To do which, we provide integrated and interoperable information to whom, when and how it is needed – to clinicians, of course, and to the patient especially. By these means, we liberate them from disconnected silos that inevitably lead to less-than-integrated care.
With advanced analytics and artificial intelligence, clinicians can show, for example, how multiple combinations of genomic attributes, prescribed drugs and test results lead to actual clinical outcomes. Using these analyses, clinical researchers can benchmark pathways and infer new best-practice, to embed improvement at great scale.



Making health and care
maximally intelligent
Innovations are being uncovered, tested and deployed far faster
Diagnostic and treatment decisions are aided by AI-driven guidance
Far less unplanned care is needed
People can access personalised intelligence-driven digital health services
People with complex multi-morbidities have better outcomes, due to intelligence-driven pathways.






Our Services
Our “Future Perfect” for Healthcare:
making health and care maximally intelligent will be achieved by:
Creating the evidence base needed to inform how to care (or self-care), making it relevant, extensive, constantly expanded and updated
Collecting the data from across prescribing, diagnostic, genomic, robotic and digital sources
Liberating and democratising the data, breaking down silos, making it ready for us to develop and deploying new applications for advanced analyses
Deploying AI tools to analyse such massive data - for example, to show the actual clinical outcomes people experience linked to their genomic attributes, diagnostic and interventive procedures and prescribed drugs
Using these analyses to benchmark and infer new best-practice
Closing the loop and re-do the cycle, embedding improvement at great scale.
We are engaged to advise several genome programmes and e-Prescribing implementations. Our Clinical Safety consultancy assures DCB 0129 and DCB 0160 standards and can support Medical Device certifications.
Our very senior clinical advisors are highly experienced in embedding innovation through relevant engagement and change management. We work on Benefits realisation and Change Management in the NHS.
To carry through their advice, Future Perfect (Healthcare) employs technical development experts in the OpenEHR standard, which is of growing importance in making healthcare far more integrated than hitherto, in UK and across Europe. Our OpenEHR tools enable integration and interoperability, essential to deploying advanced analytics, clinical decision support and AI.
Our specialist engineers can achieve highly affordable systems integration that overcome even the smallest obstacles to prevent data lock-in.
"We were faced with the task of implementing our new ePMA system and at the same time tracking and monitoring the benefits we had anticipated to report back to the DOH. The consultants now with Future Perfect (Healthcare) worked with us to set up the methodology and a tracking sheet. All we need to do each month now is put in some basic data and the savings are calculated. This has saved us a huge amount of time and we have enjoyed working with the consultants."
- ePMA Pharmacist at The Norfolk and Norwich NHS Foundation Trust


About Us
Innovations are being uncovered, tested, and deployed far faster
Far less unplanned care is needed
People can access personalised intelligence-driven digital health services
Diagnostic and treatment decisions are aided by AI-driven guidance
People with complex multi-morbidities have better outcomes, due to intelligence-driven pathways.


Who We Are

Our Customers
From a standing start in April 2020, we already have six major customers in various stages of building new pathways that will be driven by new intelligence. It is new, because it is using and integrating data (genomic, lab-testing, imaging and prescribing data) at a scale never hitherto done before.
“We were impressed by patients’ demand for our products in the UK market, but were concerned to overcome obstacles in our supply chain. Robin Stern’s persistence and grasp of NHS processes and commercial realism enabled him to build effective relationships with the regulator, which won through.”
- Erez Raphael, Chairman and CEO of DarioHealth Corp
